How should a 13-year-old male with epigastric burning after consuming acidic or spicy foods (e.g., Takis chips) and a single episode of vomiting, without fever or chills, be managed?

Management of Epigastric Burning in a 13-Year-Old

This 13-year-old male with epigastric burning triggered by acidic/spicy foods and a single vomiting episode should be managed with dietary modification (avoiding trigger foods), reassurance, and empirical acid suppression therapy with a proton pump inhibitor (PPI) if symptoms persist beyond 4 weeks. 1

Initial Assessment and Risk Stratification

At age 13, this patient does not meet criteria for urgent endoscopy. Alarm symptoms requiring immediate endoscopy include: persistent vomiting (not present here with only one episode), weight loss, gastrointestinal bleeding, dysphagia, or family history of gastric/esophageal cancer 1. Since none are present, outpatient management is appropriate.

The symptom pattern—epigastric burning after acidic/spicy foods (Takis chips)—suggests acid-related dyspepsia, likely representing either functional dyspepsia or gastroesophageal reflux disease (GERD).

Management Algorithm

Step 1: Immediate Management (Symptoms <4 weeks)

• Dietary counseling: Advise avoiding identified triggers (acidic foods, spicy chips, high-fat foods) 1, 2
• Lifestyle modifications: Regular aerobic exercise (strong recommendation) 1
• Reassurance and watchful waiting: For symptoms lasting less than 4 weeks, over-the-counter antacids and observation are appropriate 3
• Ensure adequate hydration after the vomiting episode

Step 2: If Symptoms Persist ≥4 Weeks

Test for Helicobacter pylori infection using stool antigen or urea breath test (NOT serology, which has lower specificity) 1:

• If H. pylori positive: Provide eradication therapy (antibiotics). This eliminates peptic ulcer risk and may improve symptoms 1
• If H. pylori negative OR symptoms persist after eradication: Proceed to empirical acid suppression

Step 3: Empirical Acid Suppression

For epigastric pain/burning (ulcer-like dyspepsia), PPIs are first-line therapy 1, 3:

• Start with standard-dose PPI (e.g., omeprazole 20 mg once daily) 3
• Use the lowest effective dose that controls symptoms 1
• PPIs are well-tolerated with strong evidence for efficacy in functional dyspepsia 1
• Alternative: H2-receptor antagonists (weaker evidence but acceptable) 1

Step 4: Response Assessment

• If symptoms resolve: Consider trial withdrawal of therapy after initial course, with resumption if symptoms recur 3
• If symptoms persist: Consider switching medication class (e.g., PPI to prokinetic if fullness/bloating develops, though this is not the predominant symptom here) 3
• If still refractory: Refer to gastroenterology for endoscopy and specialist evaluation 1

Key Clinical Pitfalls to Avoid

Do NOT routinely perform:

• Upper GI series for diagnosis (too brief to detect pathologic reflux, high false-positive rate) 4
• Gastric emptying studies or 24-hour pH monitoring in typical cases 1
• Endoscopy in young patients without alarm symptoms 1

Important caveat: While the 2022 British Society of Gastroenterology guidelines 1 note insufficient evidence for specific dietary therapies like low-FODMAP diets, practical avoidance of known trigger foods (acidic, spicy) is reasonable based on the patient's clear symptom pattern 2.

When to Escalate Care

Refer to gastroenterology if:

• Symptoms are severe or significantly impact quality of life
• No response to first-line and second-line therapies
• New alarm symptoms develop
• Diagnostic uncertainty exists 1

The evidence strongly supports this stepwise approach, with the most recent 2022 guidelines 1 providing high-quality evidence (strong recommendation) for both H. pylori test-and-treat strategy and empirical PPI therapy in functional dyspepsia. This approach balances symptom relief with cost-effectiveness while avoiding unnecessary invasive testing in a low-risk adolescent.